197 related articles for article (PubMed ID: 21791622)
21. MRS glucose mapping and PET joining forces: re-evaluation of the lumped constant in the rat brain under isoflurane anaesthesia.
Alf MF; Duarte JM; Lei H; Krämer SD; Mlynarik V; Schibli R; Gruetter R
J Neurochem; 2014 May; 129(4):672-82. PubMed ID: 24471521
[TBL] [Abstract][Full Text] [Related]
22. Brain glucose transport and phosphorylation under acute insulin-induced hypoglycemia in mice: an 18F-FDG PET study.
Alf MF; Duarte JM; Schibli R; Gruetter R; Krämer SD
J Nucl Med; 2013 Dec; 54(12):2153-60. PubMed ID: 24159048
[TBL] [Abstract][Full Text] [Related]
23. Facilitated transport of glucose from blood to brain in man and the effect of moderate hypoglycaemia on cerebral glucose utilization.
Blomqvist G; Gjedde A; Gutniak M; Grill V; Widén L; Stone-Elander S; Hellstrand E
Eur J Nucl Med; 1991; 18(10):834-7. PubMed ID: 1743207
[TBL] [Abstract][Full Text] [Related]
24. Rapid steady-state analysis of blood-brain glucose transfer in rat.
Gjedde A
Acta Physiol Scand; 1980 Apr; 108(4):331-9. PubMed ID: 6998256
[TBL] [Abstract][Full Text] [Related]
25. Glucose transport and utilization in the human brain: model using carbon-11 methylglucose and positron emission tomography.
Feinendegen LE; Herzog H; Wieler H; Patton DD; Schmid A
J Nucl Med; 1986 Dec; 27(12):1867-77. PubMed ID: 3491192
[TBL] [Abstract][Full Text] [Related]
26. Simplified (13)C metabolic modeling for simplified measurements of cerebral TCA cycle rate in vivo.
Valette J; Boumezbeur F; Hantraye P; Lebon V
Magn Reson Med; 2009 Dec; 62(6):1641-5. PubMed ID: 19780166
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive measurements of the cerebral steady-state glucose concentration and transport in humans by 13C nuclear magnetic resonance.
Gruetter R; Novotny EJ; Boulware SD; Rothman DL; Mason GF; Shulman GI; Tamborlane WV; Shulman RG
Adv Exp Med Biol; 1993; 331():35-40. PubMed ID: 8333347
[No Abstract] [Full Text] [Related]
28. Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation.
Chen W; Novotny EJ; Zhu XH; Rothman DL; Shulman RG
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9896-900. PubMed ID: 8234332
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo.
Möller HE; Weglage J; Wiedermann D; Vermathen P; Bick U; Ullrich K
Brain Res; 1997 Dec; 778(2):329-37. PubMed ID: 9459550
[TBL] [Abstract][Full Text] [Related]
30. Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.
Kuwabara H; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1990 Mar; 10(2):180-9. PubMed ID: 2303534
[TBL] [Abstract][Full Text] [Related]
31. Comparison of regional blood-brain transport kinetics between glucose and fluorodeoxyglucose.
Lear JL; Ackerman RF
J Nucl Med; 1992 Oct; 33(10):1819-24. PubMed ID: 1403150
[TBL] [Abstract][Full Text] [Related]
32. Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using (13)C nuclear magnetic resonance spectroscopy.
Henry PG; Criego AB; Kumar A; Seaquist ER
Metabolism; 2010 Jan; 59(1):100-6. PubMed ID: 19766263
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of blood-brain transport of hexoses.
Pardridge WM; Oldendorf WH
Biochim Biophys Acta; 1975 Mar; 382(3):377-92. PubMed ID: 1125240
[TBL] [Abstract][Full Text] [Related]
34. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia.
Segel SA; Fanelli CG; Dence CS; Markham J; Videen TO; Paramore DS; Powers WJ; Cryer PE
Diabetes; 2001 Aug; 50(8):1911-7. PubMed ID: 11473055
[TBL] [Abstract][Full Text] [Related]
35. Quantitative kinetic modelling and mapping of cerebral glucose transport and metabolism using glucoCESL MRI.
Dickie BR; Jin T; Wang P; Hinz R; Harris W; Boutin H; Parker GJ; Parkes LM; Matthews JC
J Cereb Blood Flow Metab; 2022 Nov; 42(11):2066-2079. PubMed ID: 35748031
[TBL] [Abstract][Full Text] [Related]
36. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
[TBL] [Abstract][Full Text] [Related]
37. Oxidative glucose metabolism in rat brain during single forepaw stimulation: a spatially localized 1H[13C] nuclear magnetic resonance study.
Hyder F; Rothman DL; Mason GF; Rangarajan A; Behar KL; Shulman RG
J Cereb Blood Flow Metab; 1997 Oct; 17(10):1040-7. PubMed ID: 9346428
[TBL] [Abstract][Full Text] [Related]
38. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET.
Dunn JT; Anthony K; Amiel SA; Marsden PK
J Cereb Blood Flow Metab; 2009 May; 29(5):1059-67. PubMed ID: 19293824
[TBL] [Abstract][Full Text] [Related]
39. Use of 3-fluoro-deoxyglucose for the assessment of cerebral perfusion and glucose transport. I. Theory.
Vyska K; Mehdorn HM; Machulla HJ; Knust EJ
Neurol Res; 1985 Jun; 7(2):63-7. PubMed ID: 2863771
[TBL] [Abstract][Full Text] [Related]
40. In vivo determination of the kinetic parameters of glucose transport in the human brain using 11C-methyl-D-glucose (CMG) and dynamic positron emission tomography (dPET).
Vyska K; Magloire JR; Freundlieb C; Höck A; Becker V; Schmid A; Feinendegen LE; Kloster G; Stöcklin G; Schuier FJ
Eur J Nucl Med; 1985; 11(4):97-106. PubMed ID: 3876936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
